Career history of René Muttenzer
Former positions of René Muttenzer
| Companies | Position | Start | End |
|---|---|---|---|
| ACINO HOLDING AG | Director/Board Member | 16/11/2009 | 30/03/2012 |
| NOVARTIS AG | Corporate Officer/Principal | - | - |
Posbelduf Biotech AG
 Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland. | Director/Board Member | 02/03/2011 | - |
| SPEXIS AG | Director/Board Member | 16/11/2009 | - |
Training of René Muttenzer
| University of Basel | Graduate Degree |
Statistics
International
| Switzerland | 6 |
Operational
| Director/Board Member | 3 |
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SPEXIS AG | Health Technology |
| NOVARTIS AG | Health Technology |
| Private companies | 2 |
|---|---|
Acino International AG
 Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
Posbelduf Biotech AG
Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland. | Health Technology |
- Stock Market
- Insiders
- René Muttenzer
- Experience
